Dean McGee Eye Institute
Welcome,         Profile    Billing    Logout  
 17 Trials 
12 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
SARKISIAN, STEVEN R
STAR-V, NCT05024695: Evaluate the Safety and Effectiveness of iSTAR Medical's MINIject™ Implant for Lowering Intraocular Pressure (IOP) in Subjects With Primary Open-angle Glaucoma.

Recruiting
N/A
975
Europe, Canada, US
MINIject™ Implant
iSTAR Medical
Glaucoma
07/27
07/29
Tarantino, Nicholas
TAG Project, NCT03928717: A Text-Based Adherence Game for Young People Living With HIV in Ghana

Completed
N/A
60
RoW
Text-Based Adherence Game, Standard of Care (SOC)
Rhode Island Hospital, National Institute of Mental Health (NIMH)
HIV/AIDS, Medication Adherence
03/23
08/23
Kingsley, Ronald M
VOYAGE, NCT04708145: Long-Term Efficacy and Safety of Intravitreal Aflibercept Injections for the Treatment of Diabetic Retinopathy for Subjects Who Completed the 2-Year PANORAMA Trial

Active, not recruiting
4
150
US
Aflibercept Injection, Eylea
Greater Houston Retina Research, Regeneron Pharmaceuticals, Clinical Trials Resource Group, LLC
Diabetic Retinopathy
09/24
09/24
NAC Attack, NCT05537220: Oral N-acetylcysteine for Retinitis Pigmentosa

Recruiting
3
438
Europe, Canada, US, RoW
N-acetylcysteine, Placebo
Johns Hopkins University, National Eye Institute (NEI), Duke University, Emory University, Massachusetts Eye and Ear Infirmary, Mayo Clinic, Medical College of Wisconsin, Retina Foundation of the Southwest, Stanford University, University of California, Davis, University of Florida, University of Iowa, University of Miami, University of Michigan, University of Minnesota, University of Oklahoma, University of Southern California, University of Utah, University of Washington, University of Wisconsin, Madison, Vanderbilt University, Vitreo Retinal Associates, PA, University of Houston, Medical University of Graz, McGill University, Universität Tübingen, Centro Medico ABC, Radboud University Medical Center, University of Amsterdam, University Hospital, Basel, Switzerland, University College London Hospitals, Northwestern University, University of Pennsylvania
Retinitis Pigmentosa
12/28
12/28
Protocol AF, NCT04661358: Fenofibrate for Prevention of DR Worsening

Recruiting
3
560
US
Fenofibrate, Placebo
Jaeb Center for Health Research, National Institutes of Health (NIH), National Eye Institute (NEI), Juvenile Diabetes Research Foundation, Roche Pharma AG, The Leona M. and Harry B. Helmsley Charitable Trust
Diabetic Retinopathy
04/29
04/29
NCT03094819: PROTECT2: Diabetes Care - Eye Exam

Active, not recruiting
N/A
4500
US
Financial Incentive, Retinal Care DR
Retinal Care Inc., Dean A. McGee Eye Institute
Diabetic Retinopathy, Diabetic Macular Edema
06/23
12/23
Ellis, Ashley
NAC Attack, NCT05537220: Oral N-acetylcysteine for Retinitis Pigmentosa

Recruiting
3
438
Europe, Canada, US, RoW
N-acetylcysteine, Placebo
Johns Hopkins University, National Eye Institute (NEI), Duke University, Emory University, Massachusetts Eye and Ear Infirmary, Mayo Clinic, Medical College of Wisconsin, Retina Foundation of the Southwest, Stanford University, University of California, Davis, University of Florida, University of Iowa, University of Miami, University of Michigan, University of Minnesota, University of Oklahoma, University of Southern California, University of Utah, University of Washington, University of Wisconsin, Madison, Vanderbilt University, Vitreo Retinal Associates, PA, University of Houston, Medical University of Graz, McGill University, Universität Tübingen, Centro Medico ABC, Radboud University Medical Center, University of Amsterdam, University Hospital, Basel, Switzerland, University College London Hospitals, Northwestern University, University of Pennsylvania
Retinitis Pigmentosa
12/28
12/28
NCT04417530: Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma

Completed
2
22
US
AU-011, Suprachoroidal Microinjector, PDT Laser
Aura Biosciences
Uveal Melanoma, Ocular Melanoma, Choroidal Melanoma
04/24
04/24
Jin, Douglas
NCT05832996: Cool vs Room-temperature Artificial Tears

Completed
4
124
US
Refresh Plus Preservative-free Lubricant Eye Drops
University of Iowa
Diabetic Retinopathy With Macular Edema of Both Eyes (Diagnosis), Central Retinal Vein Occlusion With Macular Edema, Exudative Age-Related Macular Degeneration, Unspecified Eye, Cystoid Macular Edema, Ocular Surface Disease, Dry Eye Sensation, Eye Pain
07/22
07/22
Icks, Sonny
NAC Attack, NCT05537220: Oral N-acetylcysteine for Retinitis Pigmentosa

Recruiting
3
438
Europe, Canada, US, RoW
N-acetylcysteine, Placebo
Johns Hopkins University, National Eye Institute (NEI), Duke University, Emory University, Massachusetts Eye and Ear Infirmary, Mayo Clinic, Medical College of Wisconsin, Retina Foundation of the Southwest, Stanford University, University of California, Davis, University of Florida, University of Iowa, University of Miami, University of Michigan, University of Minnesota, University of Oklahoma, University of Southern California, University of Utah, University of Washington, University of Wisconsin, Madison, Vanderbilt University, Vitreo Retinal Associates, PA, University of Houston, Medical University of Graz, McGill University, Universität Tübingen, Centro Medico ABC, Radboud University Medical Center, University of Amsterdam, University Hospital, Basel, Switzerland, University College London Hospitals, Northwestern University, University of Pennsylvania
Retinitis Pigmentosa
12/28
12/28
Riaz, Kamran
Apricity-A, NCT06100939: Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age With Keratoconus

Active, not recruiting
3
400
US
Riboflavin and Sodium Iodide solution and Ultraviolet-A treatment, Placebo and sham treatment
Epion Therapeutics
Keratoconus
10/25
10/25
Melson, Andrew
NCT06905912: Comparison Between Spectacles and Contact Lenses

Recruiting
N/A
200
US
Biomedics55 Premier contact lenses, and Altius Tinted Contact Lenses
University of Oklahoma, Dean A. McGee Eye Institute
Photophobia
09/25
09/25
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
SARKISIAN, STEVEN R
STAR-V, NCT05024695: Evaluate the Safety and Effectiveness of iSTAR Medical's MINIject™ Implant for Lowering Intraocular Pressure (IOP) in Subjects With Primary Open-angle Glaucoma.

Recruiting
N/A
975
Europe, Canada, US
MINIject™ Implant
iSTAR Medical
Glaucoma
07/27
07/29
Tarantino, Nicholas
TAG Project, NCT03928717: A Text-Based Adherence Game for Young People Living With HIV in Ghana

Completed
N/A
60
RoW
Text-Based Adherence Game, Standard of Care (SOC)
Rhode Island Hospital, National Institute of Mental Health (NIMH)
HIV/AIDS, Medication Adherence
03/23
08/23
Kingsley, Ronald M
VOYAGE, NCT04708145: Long-Term Efficacy and Safety of Intravitreal Aflibercept Injections for the Treatment of Diabetic Retinopathy for Subjects Who Completed the 2-Year PANORAMA Trial

Active, not recruiting
4
150
US
Aflibercept Injection, Eylea
Greater Houston Retina Research, Regeneron Pharmaceuticals, Clinical Trials Resource Group, LLC
Diabetic Retinopathy
09/24
09/24
NAC Attack, NCT05537220: Oral N-acetylcysteine for Retinitis Pigmentosa

Recruiting
3
438
Europe, Canada, US, RoW
N-acetylcysteine, Placebo
Johns Hopkins University, National Eye Institute (NEI), Duke University, Emory University, Massachusetts Eye and Ear Infirmary, Mayo Clinic, Medical College of Wisconsin, Retina Foundation of the Southwest, Stanford University, University of California, Davis, University of Florida, University of Iowa, University of Miami, University of Michigan, University of Minnesota, University of Oklahoma, University of Southern California, University of Utah, University of Washington, University of Wisconsin, Madison, Vanderbilt University, Vitreo Retinal Associates, PA, University of Houston, Medical University of Graz, McGill University, Universität Tübingen, Centro Medico ABC, Radboud University Medical Center, University of Amsterdam, University Hospital, Basel, Switzerland, University College London Hospitals, Northwestern University, University of Pennsylvania
Retinitis Pigmentosa
12/28
12/28
Protocol AF, NCT04661358: Fenofibrate for Prevention of DR Worsening

Recruiting
3
560
US
Fenofibrate, Placebo
Jaeb Center for Health Research, National Institutes of Health (NIH), National Eye Institute (NEI), Juvenile Diabetes Research Foundation, Roche Pharma AG, The Leona M. and Harry B. Helmsley Charitable Trust
Diabetic Retinopathy
04/29
04/29
NCT03094819: PROTECT2: Diabetes Care - Eye Exam

Active, not recruiting
N/A
4500
US
Financial Incentive, Retinal Care DR
Retinal Care Inc., Dean A. McGee Eye Institute
Diabetic Retinopathy, Diabetic Macular Edema
06/23
12/23
Ellis, Ashley
NAC Attack, NCT05537220: Oral N-acetylcysteine for Retinitis Pigmentosa

Recruiting
3
438
Europe, Canada, US, RoW
N-acetylcysteine, Placebo
Johns Hopkins University, National Eye Institute (NEI), Duke University, Emory University, Massachusetts Eye and Ear Infirmary, Mayo Clinic, Medical College of Wisconsin, Retina Foundation of the Southwest, Stanford University, University of California, Davis, University of Florida, University of Iowa, University of Miami, University of Michigan, University of Minnesota, University of Oklahoma, University of Southern California, University of Utah, University of Washington, University of Wisconsin, Madison, Vanderbilt University, Vitreo Retinal Associates, PA, University of Houston, Medical University of Graz, McGill University, Universität Tübingen, Centro Medico ABC, Radboud University Medical Center, University of Amsterdam, University Hospital, Basel, Switzerland, University College London Hospitals, Northwestern University, University of Pennsylvania
Retinitis Pigmentosa
12/28
12/28
NCT04417530: Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma

Completed
2
22
US
AU-011, Suprachoroidal Microinjector, PDT Laser
Aura Biosciences
Uveal Melanoma, Ocular Melanoma, Choroidal Melanoma
04/24
04/24
Jin, Douglas
NCT05832996: Cool vs Room-temperature Artificial Tears

Completed
4
124
US
Refresh Plus Preservative-free Lubricant Eye Drops
University of Iowa
Diabetic Retinopathy With Macular Edema of Both Eyes (Diagnosis), Central Retinal Vein Occlusion With Macular Edema, Exudative Age-Related Macular Degeneration, Unspecified Eye, Cystoid Macular Edema, Ocular Surface Disease, Dry Eye Sensation, Eye Pain
07/22
07/22
Icks, Sonny
NAC Attack, NCT05537220: Oral N-acetylcysteine for Retinitis Pigmentosa

Recruiting
3
438
Europe, Canada, US, RoW
N-acetylcysteine, Placebo
Johns Hopkins University, National Eye Institute (NEI), Duke University, Emory University, Massachusetts Eye and Ear Infirmary, Mayo Clinic, Medical College of Wisconsin, Retina Foundation of the Southwest, Stanford University, University of California, Davis, University of Florida, University of Iowa, University of Miami, University of Michigan, University of Minnesota, University of Oklahoma, University of Southern California, University of Utah, University of Washington, University of Wisconsin, Madison, Vanderbilt University, Vitreo Retinal Associates, PA, University of Houston, Medical University of Graz, McGill University, Universität Tübingen, Centro Medico ABC, Radboud University Medical Center, University of Amsterdam, University Hospital, Basel, Switzerland, University College London Hospitals, Northwestern University, University of Pennsylvania
Retinitis Pigmentosa
12/28
12/28
Riaz, Kamran
Apricity-A, NCT06100939: Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age With Keratoconus

Active, not recruiting
3
400
US
Riboflavin and Sodium Iodide solution and Ultraviolet-A treatment, Placebo and sham treatment
Epion Therapeutics
Keratoconus
10/25
10/25
Melson, Andrew
NCT06905912: Comparison Between Spectacles and Contact Lenses

Recruiting
N/A
200
US
Biomedics55 Premier contact lenses, and Altius Tinted Contact Lenses
University of Oklahoma, Dean A. McGee Eye Institute
Photophobia
09/25
09/25

Download Options